Peroxisomal Enzymes in the Liver of Rats With Experimental Diabetes Mellitus Type 2

Physiological Research

Volumn 63, Issue , 2014, Pages S585-S591

  Turecky L ^a   Kupcova V ^a   Uhlikova E ^a   Mojto, V ^a  

^a Faculty of Natural Sciences   (Slovakia)

Author keywords

Diabetes mellitus; Fatty liver disease; Oxidative stress; Peroxisomes

Indexed keywords

ANIMAL; ENZYMOLOGY; EXPERIMENTAL DIABETES MELLITUS; LIVER; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; PEROXISOME; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; LIVER; MALE; PEROXISOMES; RATS, WISTAR;

EID: 84925018692     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. ALICIGUZEL Y, OZEN I, ASLAN M, KARAYALCIN U: Activities of xanthine oxidase and antioxidant enzymes in different tissues of diabetic rats. J Lab Clin Med 142: 172-177, 2003.
2. ASAYAMA K, SANDHIR R, SHEIKH FG, HAYASHIBE H, NAKANE T, SINGH I: Increased peroxisomal fatty acid beta-oxidation and enhanced expression of peroxisome proliferator-activated receptor-alpha in diabetic rat liver. Mol Cell Biochem 194: 227-234, 1999.
3. BAUDHUIN P, BEAUFAY H, RAHMAN-LI Y, SELLINGER OZ, WATTIAUX R, JACQUES P, DE DUVE C: Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat liver tissue. Biochem J 92: 179-184, 1964.
4. BERNT E, BERGMEYER HU: Isocitrate dehydrogenase. In: Methods of Enzymatic Analysis, Vol. 2. HU BERGMEYER (ed), Verlag Chemie, Weinheim, 1974, pp 624-631.
5. BOVERIS A, OSHINO M, CHANCE B: The cellular production of hydrogen peroxide. Biochem J 128: 617-630, 1972.
6. CHANDOGA J: Properties and biogenesis of peroxisomes. Bratisl Lek Listy 95: 543-557, 1994.
7. CHANDOGA J, PETROVIČ R: Peroxisomes-features, biogenesis and regulation of the peroxisome genes. (in Slovak) Cas Lek Cesk 140: 8-12, 2001.
8. CHANDOGA J, ROJEKOVÁ I, HAMPL L, HOCMAN G: Cetaben and fibrates both influence the activities of peroxisomal enzyme in different ways. Biochem Pharmacol 47: 515-519, 1994a.
9. CHANDOGA J, HAMPL L, TURECKÝ L, ROJEKOVÁ I, UHLíKOVÁ E, HOCMAN G: Cetaben is an exceptional type of peroxisome proliferator. Int J Biochem 26: 679-696, 1994b.
10. CHO SY, PARK JY, PARK EM, CHOI MS, LEE MK, JEON SM, JANG MK, KIM MJ, PARK YB: Alteration of hepatic antioxidant enzyme activities and lipid profile in streptozotocin-induced diabetic rats by supplementation of dandelion water extract. Clin Chim Acta 317: 109-117, 2002.
11. DAY CP, JAMES OFW: Steatohepatitis-a tale of two "hits"? Gastroenterology 114: 842-845, 1998.
12. DELLILE HK, BONEKAMP NA, SCHRADER M: Peroxisomes and disease-an overview. Int J Biomed Sci 2: 308- 314, 2006.
13. DERKACH KV, MOYSEYUK IV, CHISTYAKOVA OV, SHPAKOV AO: Androgen deficiency in male rats with prolonged neonatal streptozotocin diabetes. Bull Exp Biol Med 155: 339-342, 2013.
14. DEVASAGAYAM TP: Lipid peroxidation in rat uterus. Biochim Biophys Acta 876: 507-514, 1986.
15. DEVASAGAYAM TP, TARACHAND U: Pregnancy-associated decrease in lipid peroxidation in rat liver. Biochem Int 16: 45-52, 1988.
16. DIEHL AM: Endotoxins and cytokines in the pathogenesis of non-alcoholic steatohepatitis. In: Steatohepatitis. U LEUSCHNER, O JAMES, H DANCYGIER (eds), Kluwer Academic Publishers, Dordrecht, 2000, pp 62- 68.
17. ENGELS W, VAN BILSEN M, WOLFFENBUTTEL BH, VAN DER VUSSE GJ, GLATZ JF: Cytochrome P450, peroxisome proliferation and cytoplasmic fatty acid-binding protein content in liver, heart and kidney of the diabetic rat. Mol Cell Biochem 192: 53-61, 1999.
18. ISLAM MS, LOOTS DU T: Experimental rodent models of type 2 diabetes: a review. Methods Find Exp Clin Pharmacol 31: 249-261, 2009.
19. IWASE M: A new animal model of non-insulin-dependent diabetes mellitus with hypertension: neonatal streptozotocin treatment in spontaneously hypertensive rats. Fukuoka Igaku Zasshi 82: 415-427, 1991.
20. JAMES OFW: Diagnosis of non-alcoholic steatohepatitis. In: Steatohepatitis. U LEUSCHNER, O JAMES, H DANCYGIER (eds), Kluwer Academic Publishers, Dordrecht, 2000, pp 34-39.
21. JOHNSON RN, METCALF PA, BAKER JR: Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 127: 87-95, 1982.
22. KAKKAR R, KALRA J, MANTHA SV, PRASAD K: Lipid peroxidation and activity of antioxidant enzymes in diabetic rats. Mol Cell Biochem 151: 113-119, 1995.
23. KAYA-DAGISTANLI F, OZTURK M: The role of clusterin on pancreatic beta cell regeneration after exendin-4 treatment in neonatal streptozotocin administrated rats. Acta Histochem 115: 577-586, 2013.
24. LOWRY OH, ROSENBROUGH NJ, FARR AL, RANDALL RJ: Protein measurement with Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
25. LUCCHESI AN, FREITAS NT, CASSETTARI LL, MARQUES SF, SPADELLA CT: Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats. A mechanism for diabetic chronic liver disease. Acta Cir Bras 28: 502-508, 2013.
26. MARCHESINI G, BRIZI M, MORSELLI-LABATE AM, BIANCHI G, BUGIANESI E, MCCULLOUGH AJ, FORLANI G, MELCHIONDA N: Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107: 450-455, 1999.
27. MARITIM AC, SANDERS RA, WATKINS JB: Effects of alpha-lipoic acid on biomarkers of oxidative stress in streptozotocin-induced diabetic rats. J Nutr Biochem 14: 288-294, 2003.
28. MATTEONI CA, YOUNOSSI ZM, GRAMLICH T, BOPARAI N, LIU YC, MCCULLOUGH AJ: Nonalcoholic fatty liver disease: a spectrum of clinical pathological severity. Gastroenterology 116: 1413-1419, 1999.
29. MIHARA K, SATO R: Detergent-solubilized NADH-cytochrome b5 reductase. In: Methods in Enzymology, Vol. 52. SP COLOWICK, NO KAPLAN (eds), Academic Press, New York, 1978, pp 102-108.
30. NIEDERLAND TR, GVOZDJÁK J, TRIZNOVÁ M: The determination of glycogen in tissues. (in Slovak) Bratisl Lek Listy 36: 95-103, 1956.
31. PORTHA B, GIROIX MH, KERGOAT M, BAILBE D, BLONDEL O, SERRADAS P: Animal models of non-insulindependent diabetes induced in the rat by experimental reduction of B cell mass. Journ Annu Diabetol Hotel Dieu: 33-46, 1988.
32. RAJARAJESWARI N, PARI L: Antioxidant role of coumarin on streptozotocin-nicotinamide-induced type 2 diabetic rats. J Biochem Mol Toxicol 25: 355-361, 2011.
33. RECALCATI S, TACCHINI L, ALBERGHINI A, CONTE D, CAIRO G: Oxidative stress-mediated down-regulation of rat hydroxyacid oxidase 1, a liver-specific peroxisomal enzyme. Hepatology 38: 1159-1166, 2003.
34. SHARMA AK, RAIKWAR SK, KURMI MK, SRINIVASAN BP: Gemfibrozil and its combination with metformin on pleiotropic effect on IL-10 and adiponectin and anti-atherogenic treatment in insulin resistant type 2 diabetes mellitus rats. Inflammopharmacology 21: 137-145, 2013.
35. SINGH R, BHARDWAJ P, SHARMA P: Antioxidant and toxicological evaluation of Cassia sophera in streptozotocininduced diabetic Wistar rats. Pharmacognosy Res 5: 225-232, 2013.
36. SINHA AK: Colorimetric assay of catalase. Anal Biochem 47: 389-394, 1972.
37. THOMAS H, SCHLADT L, KNEHR M, OESCH F: Effect of diabetes and starvation on the activity of rat liver epoxide hydrolases, glutathione S-transferases and peroxisomal beta-oxidation. Biochem Pharmacol 38: 4291-4297, 1989.
38. TURECKý L, KUPCOVÁ V, MOJTO V, SMUTNý M, UHLíKOVÁ E, VOZÁR I: Serum cholinesterase activity and proteosynthetic function of the liver in patients with diabetes mellitus. Bratisl Lek Listy 106: 266-269, 2005.